// App-Quantinova.ai

Filters

Biomarkers











Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























7277 Abstracts

Have Newer Generation Drug-Eluting Stents Improved The Long-Term Outcome Of Saphenous Vein Graft Intervention?

Philip Durney - American Heart Association (AHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Quantitative Assessment of Vascular Response After Drug-Eluting Stent Implantation in Patients: A Polarization-Sensitive Optical Frequency Domain Imaging Study

Kenichiro Otsuka - American Heart Association (AHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Assessment of Dual Antiplatelet Therapy versus Low-dose Rivaroxaban in Atrial Fibrillation Patients Treated With Left Atrial Appendage Closure: The Randomized Adrift Study

Guillaume Duthoit - American Heart Association (AHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

rivaroxaban

Stent Thrombosis With and Without Aspirin After Pci in Patients With Atrial Fibrillation

Nick D Fagel - American Heart Association (AHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Aspirin

Personalized Antiplatelet Therapy Guided by a Novel Detection of Platelet Aggregation Function in Stable Coronary Artery Disease Patients Undergoing Pci: A Randomized Controlled Clinical Trial

Ying-Ying Zheng - American Heart Association (AHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Excimer Laser and Following Heparin Infusion Therapy is an Effective Therapy for Intraprocedual Stent Thrombosis

Akihiro Tanaka - American Heart Association (AHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Heparin

Clinical Effects of Shorter Dual Antiplatelet Therapy Duration After Drug-Eluting Stents: A Network Bayesan Meta-Analysis of Randomized Clinical Trials

Giuseppe Ferrante - American Heart Association (AHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Network Meta Analysis of Regimens in Patients With Atrial Fibrilation Undergoing Percutanoues Coronary Intervention

Alexander Ivanov - American Heart Association (AHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Aspirin

Dual Antiplatelet Therapy for Three Months Followed by Monotherapy is Non-inferior to One Year Dual Antiplatelet Therapy in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention- A Systematic Review and Meta-Analysis

Muhammad Fazeel Anwar - American Heart Association (AHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Cardiovascular Effects of Chimeric Antigen Receptor T-Cell (CART Cell) Therapy in Adults

Benedicte Lefebvre - American Heart Association (AHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Sex Based Differences in Outcomes Among Patients Undergoing Catheter Directed Therapy for Pulmonary Embolism

Srilekha Sridhara - American Heart Association (AHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

NEDD9 Regulates Platelet-endothelial Adhesion and Pulmonary Arterial Thrombosis: Implications for Chronic Thromboembolic Pulmonary Hypertension

George A Alba - American Heart Association (AHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Adenosine

Long-term Clinical Outcomes of Long Coronary Lesions in Acute Myocardial Infarction Patients Underwent Percutaneous Coronary Intervention

Seung Woon Rha - American Heart Association (AHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Oral Anticoagulant for Atrial Fibrillation in Patients on Dialysis: Insights From a Network Meta-analysis

Toshiki Kuno - American Heart Association (AHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

apixaban

Dual Antiplatelet Therapy After Left Atrial Appendage Occlusion With the Watchman Device

Erika Hutt - American Heart Association (AHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Impact of Concomitant Deep Vein Thrombosis on Clinical Outcomes in Patients With Acute Pulmonary Embolism

Shushi Nishiwaki - American Heart Association (AHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Anti-factor Xa Activity Value At Peak And Trough Times In High Risk Patients With Venous Thromboembolism On Apixaban Therapy

Ryohei Ono - American Heart Association (AHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

apixaban

Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness: Pooled Analysis of Mortality and Major Thromboembolic Events in 16,496 Patients From the MAGELLAN and MARINER Trials

Gary E Raskob - American Heart Association (AHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

rivaroxaban

Use of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) Venous Thromboembolism Risk Model and Elevated D-Dimer to Identify a High Venous Thromboembolism Risk in an Acutely Ill Medical Population for Extended Thromboprophylaxis

Alex C Spyropoulos - American Heart Association (AHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

rivaroxaban

Time Course and Outcomes of Major Bleeding Events According to Bleeding Site in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism

Behnood Bikdeli - American Heart Association (AHA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Copyright © 2026. QuantiNova All rights reserved